MedPath

Ethanol

Generic Name
Ethanol
Brand Names
Dalmacol, Gattex, Healing Waters Aloe Cucumber Hand Sanitizer, Healing Waters Cotton Blossom Hand Sanitizer, Healing Waters Lemon Verbena Hand Sanitizer, Healing Waters Peach Nectarine Hand Sanitizer, Lupaneta Pack 1-month, Viva-drops Lubricating Eye Drops
Drug Type
Small Molecule
Chemical Formula
C2H6O
CAS Number
64-17-5
Unique Ingredient Identifier
3K9958V90M
Background

A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in alcoholic beverages.

Indication

For therapeutic neurolysis of nerves or ganglia for the relief of intractable chronic pain in such conditions as inoperable cancer and trigeminal neuralgia (tic douloureux), in patients for whom neurosurgical procedures are contraindicated.

Associated Conditions
Bacterial Infections, Obstructive Hypertrophic Cardiomyopathy, Skin Irritation, Bacterial skin infections, Ethylene glycol overdose, Fat occlusion in central venous catheter, Methanol overdose
Associated Therapies
Hand Hygiene, Skin disinfection

Percutaneous Ethanol Injection for Primary Papillary Thyroid Microcarcinoma

Not Applicable
Terminated
Conditions
Papillary Thyroid Cancer
Interventions
First Posted Date
2013-11-01
Last Posted Date
2019-11-25
Lead Sponsor
Yale University
Target Recruit Count
7
Registration Number
NCT01974284
Locations
🇺🇸

Endocrine Surgery Smilow Cancer Hospital at Yale-New Haven, New Haven, Connecticut, United States

Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation

Phase 2
Completed
Conditions
Ventricular Tachycardia
Atrial Fibrillation
Interventions
Procedure: Ablation
First Posted Date
2013-07-12
Last Posted Date
2020-09-30
Lead Sponsor
Miguel X. Valderrabano, MD
Target Recruit Count
423
Registration Number
NCT01898221
Locations
🇺🇸

Emory University Hospital, Atlanta, Georgia, United States

🇺🇸

Houston VAMC, Houston, Texas, United States

🇺🇸

University of Colorado School of Medicince, Denver, Denver, Colorado, United States

and more 9 locations

Pilot Study of the Safety of a Daily Ethanol Lock for Urinary Catheters in Critically Ill Children

Phase 1
Completed
Conditions
Complication of Urinary Catheter
Interventions
First Posted Date
2013-05-31
Last Posted Date
2018-06-28
Lead Sponsor
Children's Healthcare of Atlanta
Target Recruit Count
10
Registration Number
NCT01865708
Locations
🇺🇸

Children's Helathcare of Atlanta at Egleston, Atlanta, Georgia, United States

Effectiveness of Lavage With Alcohol - Chlorhexidine for Chemical Matricectomy

Phase 4
Conditions
Ingrown Toenail
Interventions
First Posted Date
2013-05-01
Last Posted Date
2013-05-01
Lead Sponsor
Universidad Complutense de Madrid
Target Recruit Count
40
Registration Number
NCT01844141
Locations
🇪🇸

Universidad Complutense de Madrid (Podología), Madrid, Spain

Ghrelin for Alcohol Use in Non-Treatment-Seeking Heavy Drinkers

Phase 2
Completed
Conditions
fMRI
Alcohol Drinking
Alcoholism
Interventions
Drug: Placebo
Procedure: fMRI
First Posted Date
2013-01-29
Last Posted Date
2018-08-03
Lead Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Target Recruit Count
17
Registration Number
NCT01779024
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

An Investigator-Initiated Study to Assess the Cooling Effect of Triamcinolone Acetonide Aerosol When Used for Steroid-Responsive Dermatoses

Not Applicable
Completed
Conditions
Acute Steroid Responsive Dermatoses
Chronic Steroid Responsive Dermatoses
Interventions
First Posted Date
2012-11-29
Last Posted Date
2012-12-04
Lead Sponsor
Patel, Rita Vikram, M.D.
Target Recruit Count
30
Registration Number
NCT01736670
Locations
🇺🇸

Mount Sinai School of Medicine, New York, New York, United States

Alcohol Inhibits Drug Metabolism by Carboxylesterases

Phase 1
Completed
Conditions
Drug Interactions
Interventions
First Posted Date
2012-10-16
Last Posted Date
2012-10-16
Lead Sponsor
University of Tennessee
Target Recruit Count
19
Registration Number
NCT01708369
Locations
🇺🇸

University of Tennessee Health Science Center, Memphis, Tennessee, United States

Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans

Phase 1
Completed
Conditions
Active Ethanol and Placebo Iomazenil
Active Ethanol and Active Iomazenil
Placebo Ethanol and Active Iomazenil
Placebo Ethanol and Placebo Iomazenil
Alcohol Effect
Driving Under the Influence
Alcohol Impairment
Interventions
First Posted Date
2012-05-02
Last Posted Date
2024-10-09
Lead Sponsor
VA Office of Research and Development
Target Recruit Count
33
Registration Number
NCT01590277
Locations
🇺🇸

VA Connecticut Healthcare System West Haven Campus, West Haven, CT, West Haven, Connecticut, United States

Evaluation of the Pharmacodynamic and Pharmacokinetic Interactions of Tasimelteon and Ethanol

Phase 1
Completed
Conditions
Pharmacodyamics and Pharmacokinetics of Tasimelteon Alone and in Combination With Ethanol
Interventions
First Posted Date
2012-04-16
Last Posted Date
2014-02-17
Lead Sponsor
Vanda Pharmaceuticals
Target Recruit Count
28
Registration Number
NCT01578057
Locations
🇨🇦

INC Research Toronto, Inc., Toronto, Ontario, Canada

Hub Cleansing to Prevent Hub Infection

Not Applicable
Completed
Conditions
Bacteremia
Interventions
Other: 5 second scrub
Other: 15 second scrub
Drug: 3.15% chlorhexidine/70% isopropyl alcohol
First Posted Date
2012-03-27
Last Posted Date
2016-04-18
Lead Sponsor
Rush University Medical Center
Target Recruit Count
149
Registration Number
NCT01563406
Locations
🇺🇸

Rush University Medical Center, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath